Dianthus Therapeutics | 8-K: Current report
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer CARR EDWARD
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Veness Adam M
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Randhawa Simrat
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Savitz Ryan
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Garcia Marino
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Violin Jonathan
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Soteropoulos Paula
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOULDER LEON O JR
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McGeorge Anne
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lawton Alison Frances
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Dianthus Therapeutics | 424B3: Prospectus
Dianthus Therapeutics | 8-K: Current report
Dianthus Therapeutics | 10-Q: Quarterly report
Dianthus Therapeutics | 424B3: Prospectus
Dianthus Therapeutics | 8-K: Current report
Dianthus Therapeutics | ARS: Annual Report to Security Holders
Dianthus Therapeutics | DEFA14A: Others
Dianthus Therapeutics | DEF 14A: Definitive information statements
No Data